Natera’s $287.5 Million Follow-On Public Offering

Davis Polk advised the representatives of the several underwriters in the offering.

Natera, Inc. executed its follow-on offering of 4,791,665 shares of common stock, for total gross proceeds of approximately $287.5 million. The shares are listed on the Nasdaq Global Select Market under the symbol “NTRA.”

Based in San Carlos, California, Natera is a diagnostics company with proprietary molecular and bioinformatics technology that it deploys to change the management of disease worldwide.

The Davis Polk corporate team advising J.P. Morgan Securities LLC, Morgan Stanley & Co. LLC, Cowen and Company, LLC and SVB Leerink LLC, as representatives of the several underwriters, included partner Alan F. Denenberg (Picture) and associates Daniel Reichert and Sarah Kirk. Partner Frank J. Azzopardi and associate Hilary Smith provided intellectual property advice. The tax team included partner Patrick E. Sigmon. Associate Brantley Hawkins provided 1940 Act advice.

Involved fees earner: Frank Azzopardi – Davis Polk & Wardwell; Alan Denenberg – Davis Polk & Wardwell; Brantley Hawkins – Davis Polk & Wardwell; Sarah Kirk – Davis Polk & Wardwell; Daniel Reichert – Davis Polk & Wardwell; Patrick Sigmon – Davis Polk & Wardwell; Hilary Smith – Davis Polk & Wardwell;

Law Firms: Davis Polk & Wardwell;

Clients: Cowen and Company; J.P. Morgan Securities LLC; Morgan Stanley; SVB Leerink LLC;

Author: Ambrogio Visconti